InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: None

Tuesday, 03/06/2018 3:07:55 PM

Tuesday, March 06, 2018 3:07:55 PM

Post# of 44784
Why? The company you try to use as a comparison to our CLI trial and the speed we will get there, doesn't seem to fit your thought of approval coming quickly for us.

They got fast track in 2003, orphan drug status in 2014, initial phase 3 results in May of 2016, breakthrough designation May 2017, priority review, June 2017, and approval today.

But miraculously we are going to fly to approval. No matter what, we have a long way to go. So before you throw out clueless, research what you point out. Or do the facts I present, support your argument?

And besides, that's why they haven't updated clinical trials site since Jan of this year. Where's the 40 sites coming.

Or why are they offering rsu' sin stead of the more palatable options? If something big we're to be coming, I'm sure employees would be motivated by options alone. But ya, any day now.